254 related articles for article (PubMed ID: 20021959)
1. [An update: stem cell and cancer stem cells].
Liu YQ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):511-2. PubMed ID: 20021959
[No Abstract] [Full Text] [Related]
2. [Progress of research on breast cancer stem cell markers].
Liu X; Li W; Fu L
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):282-4. PubMed ID: 24915825
[No Abstract] [Full Text] [Related]
3. [The role of tyrosine phosphorylation of cancer stem cell marker CD133 in malignant tumor progression].
Shimozato O; Nagase H; Ozaki T
Seikagaku; 2015 Jun; 87(3):389-92. PubMed ID: 26571608
[No Abstract] [Full Text] [Related]
4. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
[TBL] [Abstract][Full Text] [Related]
5. CD133: molecule of the moment.
Mizrak D; Brittan M; Alison M
J Pathol; 2008 Jan; 214(1):3-9. PubMed ID: 18067118
[TBL] [Abstract][Full Text] [Related]
6. CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.
Wang M; Xiao J; Jiang J; Qin R
Int J Cancer; 2011 Apr; 128(8):1996-7. PubMed ID: 20568110
[No Abstract] [Full Text] [Related]
7. Cancer: Tumour stem cells switch sides.
Bautch VL
Nature; 2010 Dec; 468(7325):770-1. PubMed ID: 21150987
[No Abstract] [Full Text] [Related]
8. Cancer stem cell markers as potential targets for epithelial cancers.
Madka V; Rao CV
Indian J Exp Biol; 2011 Nov; 49(11):826-35. PubMed ID: 22126013
[TBL] [Abstract][Full Text] [Related]
9. Prominin1 (CD133) as an intestinal stem cell marker: promise and nuance.
Montgomery RK; Shivdasani RA
Gastroenterology; 2009 Jun; 136(7):2051-4. PubMed ID: 19409288
[No Abstract] [Full Text] [Related]
10. Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name?
Neuzil J; Stantic M; Zobalova R; Chladova J; Wang X; Prochazka L; Dong L; Andera L; Ralph SJ
Biochem Biophys Res Commun; 2007 Apr; 355(4):855-9. PubMed ID: 17307142
[TBL] [Abstract][Full Text] [Related]
11. Research progression of CD133 as a marker of cancer stem cells.
Zhang H; Li SY
Chin J Cancer; 2010 Mar; 29(3):243-7. PubMed ID: 20193104
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells in the central nervous system--a critical review.
Prestegarden L; Enger PØ
Cancer Res; 2010 Nov; 70(21):8255-8. PubMed ID: 20959482
[TBL] [Abstract][Full Text] [Related]
13. CD133 as a marker for cancer stem cells: progresses and concerns.
Wu Y; Wu PY
Stem Cells Dev; 2009 Oct; 18(8):1127-34. PubMed ID: 19409053
[TBL] [Abstract][Full Text] [Related]
14. [New strategies in the proteomic research on tumor stem cells].
Li M
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):321-3. PubMed ID: 25030584
[No Abstract] [Full Text] [Related]
15. Glioma formation, cancer stem cells, and akt signaling.
Hambardzumyan D; Squatrito M; Carbajal E; Holland EC
Stem Cell Rev; 2008 Sep; 4(3):203-10. PubMed ID: 18595010
[TBL] [Abstract][Full Text] [Related]
16. Targeting CD133 antigen in cancer.
Ferrandina G; Petrillo M; Bonanno G; Scambia G
Expert Opin Ther Targets; 2009 Jul; 13(7):823-37. PubMed ID: 19530986
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer stem cells: their role in pancreatic cancer patient outcomes and what is future?
Habib M; Saif MW
JOP; 2013 Jul; 14(4):401-4. PubMed ID: 23846937
[TBL] [Abstract][Full Text] [Related]
18. Cancer: stem cells and brain tumours.
Dirks PB
Nature; 2006 Dec; 444(7120):687-8. PubMed ID: 17151644
[No Abstract] [Full Text] [Related]
19. Cancer stem cells hypothesis and stem cells in head and neck cancers.
Mannelli G; Gallo O
Cancer Treat Rev; 2012 Aug; 38(5):515-39. PubMed ID: 22197808
[TBL] [Abstract][Full Text] [Related]
20. Human breast and melanoma cancer stem cells biomarkers.
La Porta CA; Zapperi S
Cancer Lett; 2013 Sep; 338(1):69-73. PubMed ID: 22445909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
